Видео ютуба по тегу Adaptive Clinical Trial

Day 4 (II) - Adaptive Study designs _ Prof. Shrikant I Bangdiwala
Day 4 (II) - Adaptive Study designs _ Prof. Shrikant I Bangdiwala
Prof. Jack Lee | Biomarker-based Bayesian Adaptive Designs for Targeted Agent Development -......
Prof. Jack Lee | Biomarker-based Bayesian Adaptive Designs for Targeted Agent Development -......
Multiple Speakers | Designing an adaptive trial with treatment selection and a survival endpoint
Multiple Speakers | Designing an adaptive trial with treatment selection and a survival endpoint
Prof. KyungMann Kim | A Bayesian Adaptive Design with Biomarkers for Targeted Therapies and Some...
Prof. KyungMann Kim | A Bayesian Adaptive Design with Biomarkers for Targeted Therapies and Some...
| An adaptive optimal design for the Emax model and its application in clinical trials
| An adaptive optimal design for the Emax model and its application in clinical trials
Prof. Frank Bretz | Response-adaptive dose-finding under model uncertainty
Prof. Frank Bretz | Response-adaptive dose-finding under model uncertainty
Prof. Anthony Atkinson | Adaptive designs for clinical trials with prognostic factors that......
Prof. Anthony Atkinson | Adaptive designs for clinical trials with prognostic factors that......
Dr. Basia Bogacka | Adaptive optimum experimental design in Phase I clinical trials
Dr. Basia Bogacka | Adaptive optimum experimental design in Phase I clinical trials
Ms. Katrin Roth | Adaptive designs for dose escalation studies - a simulation study
Ms. Katrin Roth | Adaptive designs for dose escalation studies - a simulation study
Prof. Alessandra Giovagnoli | Recent developments in adaptive clinical trials to account for......
Prof. Alessandra Giovagnoli | Recent developments in adaptive clinical trials to account for......
‘Be Truthful, but Kind’: The Importance of Adaptive Communication in Oncology Care
‘Be Truthful, but Kind’: The Importance of Adaptive Communication in Oncology Care
Адаптивные проекты испытаний в биомедицинских исследованиях (14 минут)
Адаптивные проекты испытаний в биомедицинских исследованиях (14 минут)
NACFC 2025 | W20: Cutting-edge Clinical Trials: Insights & Updates
NACFC 2025 | W20: Cutting-edge Clinical Trials: Insights & Updates
"Rare Disease Clinical Trials Market 2025-2031 | Growth, Trends & Opportunities"
Bayesian Clinical Trials: Where Are We Now? | Berry Consultants
Bayesian Clinical Trials: Where Are We Now? | Berry Consultants
CoMeCT Workshop - Breaking Barriers Streamlined Approvals for Multi Arm, Adaptive Clinical Trials
CoMeCT Workshop - Breaking Barriers Streamlined Approvals for Multi Arm, Adaptive Clinical Trials
Unlocking the Secrets of FDA Regulations!
Unlocking the Secrets of FDA Regulations!
Adaptive trial design is no longer a “future state”
Adaptive trial design is no longer a “future state”
Better Designs, Faster Answers | Berry Consultants
Better Designs, Faster Answers | Berry Consultants
Statistical Rigor in Adaptive Trials | Berry Consultants
Statistical Rigor in Adaptive Trials | Berry Consultants
Why Is Adaptive Immunity Crucial For Immunotherapy Success? - Trials and Treatments Uncovered
Why Is Adaptive Immunity Crucial For Immunotherapy Success? - Trials and Treatments Uncovered
How Does Adaptive Immunity Enhance Immunotherapy? - Trials and Treatments Uncovered
How Does Adaptive Immunity Enhance Immunotherapy? - Trials and Treatments Uncovered
What Is Adaptive Immunity In Immunotherapy Treatments? - Trials and Treatments Uncovered
What Is Adaptive Immunity In Immunotherapy Treatments? - Trials and Treatments Uncovered
Critiques and Defense of Adaptive Designs | Berry Consultants
Critiques and Defense of Adaptive Designs | Berry Consultants
The Saga of the Lecanemab Adaptive Phase II Trial
The Saga of the Lecanemab Adaptive Phase II Trial